Works matching AU Zengin, Nurullah

Results: 96
    1

    Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III 'Stop and Go' Study Results - A Turkish Oncology Group Trial.

    Published in:
    Oncology, 2013, v. 85, n. 6, p. 328, doi. 10.1159/000355914
    By:
    • Yalcin, Suayib;
    • Uslu, Ruchan;
    • Dane, Faysal;
    • Yilmaz, Ugur;
    • Zengin, Nurullah;
    • Buyukunal, Evin;
    • Buyukberber, Suleyman;
    • Camci, Celalettin;
    • Sencan, Orhan;
    • Kilickap, Sadettin;
    • Ozdener, Fatih;
    • Cevik, Duygu
    Publication type:
    Article
    2
    3
    4

    Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma.

    Published in:
    European Journal of Haematology, 1997, v. 59, n. 2, p. 100, doi. 10.1111/j.1600-0609.1997.tb00732.x
    By:
    • Kars, Ayşe;
    • Çelik, İsmail;
    • Kansu, Emin;
    • Tekuzman, Gülten;
    • Özişik, Yavuz;
    • Güler, Nilüfer;
    • Barişta, İbrahim;
    • Güllü, İbrahim;
    • Yalçin, Şuayib;
    • Altundaǧ, Kadri;
    • Zengin, Nurullah;
    • Türker, Alev;
    • Hayran, Mutlu;
    • Baltali, Eşmen;
    • Firat, Dinçer
    Publication type:
    Article
    5
    6
    7

    Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.

    Published in:
    Journal of Surgical Oncology, 2000, v. 73, n. 1, p. 12, doi. 10.1002/(sici)1096-9098(200001)73:1<12::aid-jso4>3.3.co;2-b
    By:
    • Barişta, İbrahi̇m;
    • Tekuzman, Gülten;
    • Yalçin, Şuayi̇b;
    • Güllü, İbrahi̇m;
    • Güler, Ni̇lüfer;
    • Özişik, Yavuz;
    • Kars, Ayşe;
    • Çeli̇k, İsmai̇l;
    • Türker, Alev;
    • Altundağ, Kadri̇;
    • Zengi̇n, Nurullah;
    • Üner, Ayşegül;
    • Baltali, Eşmen;
    • Firat, Di̇nçer
    Publication type:
    Article
    8

    Multiple myeloma in a patient with neurofibromatosis.

    Published in:
    American Journal of Hematology, 2007, v. 82, n. 8, p. 772, doi. 10.1002/ajh.21012
    By:
    • Zengin, Nurullah;
    • Gönül, Müzeyyen;
    • Gül, Ülker;
    • Öksüzoğlu, Berna;
    • Kiliç, Arzu;
    • Çakmak, Seray Külcü;
    • Sakinci, Ünal
    Publication type:
    Article
    9
    10
    11
    12
    13

    Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen

    Published in:
    Medical Oncology, 2014, v. 31, n. 9, p. 1, doi. 10.1007/s12032-014-0153-y
    By:
    • Sendur, Mehmet;
    • Ozdemir, Nuriye;
    • Özatlı, Tahsin;
    • Yazıcı, Ozan;
    • Aksoy, Sercan;
    • Ekinci, Ahmet;
    • Yazılıtaş, Doğan;
    • Günaydın, Yusuf;
    • Oksuzoglu, Berna;
    • Benekli, Mustafa;
    • Zengin, Nurullah
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Frequency of HCV infection in renal cell carcinoma patients.

    Published in:
    Medical Oncology, 2012, v. 29, n. 3, p. 1892, doi. 10.1007/s12032-011-9928-6
    By:
    • Budakoğlu, Burçin;
    • Aksoy, Sercan;
    • Arslan, Çağatay;
    • Üyetürk, Ümmügül;
    • Babacan, Nalan;
    • Özcan, Muhammet;
    • Yıldız, Ramazan;
    • Öven, Başak;
    • Özdemir, Nuriye;
    • Dizdar, Ömer;
    • Büyükberber, Süleyman;
    • Akıncı, M.;
    • Türker, İbrahim;
    • Öksüzoğlu, Berna;
    • Altundag, Kadri;
    • Zengin, Nurullah
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50